Kimberly Lucas Slimane
Nurse Practitioner · San Antonio, TXNPI 1003042573
Payments from drug & device makers
Across 574 payments — averaging $19.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$2K
- Boehringer Ingelheim$878
- Mylan Specialty L.p.$629
- Grifols USA, LLC$581
- AbbVie$447
- plus $4K from 32 others
What the payments were for
- Food & beverage$10,94699%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 149 | $2,427 |
| AstraZeneca | 99 | $2,025 |
| Boehringer Ingelheim | 41 | $878 |
| Mylan Specialty L.p. | 34 | $629 |
| Grifols USA, LLC | 25 | $581 |
| AbbVie | 22 | $447 |
| Baxter Healthcare | 21 | $391 |
| Electromed, Inc. | 31 | $385 |
| Insmed, Inc. | 20 | $332 |
| Regeneron Healthcare Solutions, Inc. | 11 | $287 |
| Jazz Pharmaceuticals Inc. | 9 | $260 |
| Philips North America LLC | 15 | $252 |
| Johnson & Johnson | 10 | $224 |
| United Therapeutics Corporation | 9 | $222 |
| Sanofi | 9 | $193 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $174 |
| Actelion Pharmaceuticals US, Inc. | 7 | $153 |
| Tactile Systems Technology Inc | 5 | $147 |
| Novartis | 5 | $108 |
| Harmony Biosciences LLC | 5 | $104 |
| Mallinckrodt Hospital Products Inc. | 5 | $102 |
| Axsome Therapeutics, Inc. | 5 | $102 |
| Fisher & Paykel Healthcare Inc | 3 | $83 |
| Genentech USA, Inc. | 4 | $79 |
| Medtronic | 2 | $60 |
| Inspire Medical Systems, Inc. | 2 | $48 |
| Viatris Specialty LLC | 2 | $45 |
| Advanced Respiratory, Inc | 2 | $43 |
| Amgen | 3 | $42 |
| Gilead | 3 | $42 |
| ANI Pharmaceuticals, Inc. | 2 | $35 |
| Verona Pharma, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Merck | 1 | $19 |
| Pfizer | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Alk-abello, Inc | 1 | $16 |
| Shionogi Inc | 1 | $14 |
How this compares
$11,030 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 546 | $475,511 |
| OfevNintedanib Esylate | 12 | $158,090 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 56 | $44,336 |
| Breo ElliptaFluticasone/Vilanterol | 58 | $25,098 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 24 | $22,692 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 12 | $12,996 |
| Spiriva RespimatTiotropium Bromide | 15 | $9,759 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 55 | $6,704 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $6,544 |
| Varenicline Tartrate | 14 | $5,146 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 166 | $4,907 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $3,096 |
| Montelukast Sodium | 110 | $1,331 |
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 28 | $1,228 |
| Roflumilast | 11 | $1,074 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $2,427 | $523,302628 claims |
| Boehringer IngelheimOfev, Combivent Respimat, Spiriva Respimat | $878 | $180,84439 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $2,025 | $50,88078 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in San Antonio
- Corrie BerkSan Antonio$155K
- Sonja BruneSan Antonio$51K
- Laura GalvanSan Antonio$32K
- Eduardo GonzalezSan Antonio$32K
- Roberta RomeroSan Antonio$26K
- Christopher GarciaSan Antonio$21K
- Jennifer ZavalaSan Antonio$17K
- Amy RivasSan Antonio$17K
- Erika SimpsonSan Antonio$16K
- Alexis WahlenSan Antonio$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.